학술논문
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses
Document Type
Article
Author
Source
In: Pharmacology Research and Perspectives . (Pharmacology Research and Perspectives, April 2024, 12(2))
Subject
Language
English
ISSN
20521707